ArticleActa biochimica et biophysica Sinica2025
The expression profile of type 1 equilibrative nucleoside transporter in aged C57BL/6J mouse brain.
Article in Acta biochimica et biophysica Sinica, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The type 1 equilibrative nucleoside transporter (ENT1) is essential for regulating extracellular adenosine levels and has been implicated in various psychiatric disorders. While previous studies have investigated the expression of ENT1 in fetal and neonatal brains, its neuroanatomical distribution in adult and aged mouse brains has not been fully elucidated. Therefore, in this study, we utilize immunohistochemistry and double-immunofluorescence techniques to map the expression of ENT1 across various brain regions. Our findings demonstrate that ENT1-positive cells are widely distributed throughout the brain, with particularly high expression observed in the cerebral cortex and hippocampus. ENT1 is expressed predominantly in neurons, particularly in cholinergic, dopaminergic and glutamatergic neurons. Furthermore, ENT1 is localized primarily to the mitochondria and lysosomes and is expressed to a lesser extent in the Golgi apparatus and endoplasmic reticulum. Notably, we find an age-dependent increase in ENT1 expression in the cerebral cortex, suggesting a potential role in age-related cognitive functions. This study highlights the regionally specific expression of ENT1 in the brain, providing a new morphological basis for understanding its potential roles in brain physiology. Additionally, given its involvement in neurotransmitter regulation, ENT1 may have important implications for neurological and psychiatric disorders. This work lays the groundwork for future studies exploring the implications of ENT1 in neurodegenerative diseases and other aging-related brain disorders.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.